BioAffinity Technologies Inc
BIAF
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.77M
Close$
$0.13
97.9% downside
Current Fair Value
97.9% downsideOvervalued by 97.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.77 Million |
|---|---|
| Enterprise Value | $10.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-129.9 |
| Beta | -1.12 |
| Outstanding Shares | 348,450 |
Return
| Return on Equity | -402.92% |
|---|---|
| Return on Assets | -199.30% |
| Return on Invested Capital | -220.05% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0.29 |
| Price to Sales | 0.39 |
| Price to Book Ratio | 0.62 |
| Enterprise Value to Revenue | 1.83 |
| Enterprise Value to EBIT | -0.99 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-2.10
Average shareholder expectationRevenue Estimate
$1.70 M
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-31.50
Average shareholder expectationRevenue Estimate
$1.91 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.42%▲ 10.03% |
|---|---|
| Total Invested | $782,494▼ 15.72% |
| Investors Holding | 20▲ 6.00% |
ESG Score
No data